Hydroponic Cultivation in Systemic Nickel Allergy Syndrome (DATTERINO)
Primary Purpose
Food Allergy, Food Hypersensitivity, Nickel Sensitivity
Status
Completed
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
Datterino tomato purée from hydroponic technology
Datterino tomato puree from conventional cultivation
Sponsored by
About this trial
This is an interventional treatment trial for Food Allergy focused on measuring Systemic Nickel Allergy Syndrome, Hydroponic cultivation, Tomato, Quality of life, Intestinal permeability
Eligibility Criteria
Inclusion Criteria:
- Patients with documented diagnosis of SNAS: a) history of SNAS (coexistence of typical skin symptoms and gastrointestinal symptoms); b) positive nickel sulphate patch test; c) clinical improvement of at least 70% after 4-6 weeks of low-nickel diet; d) positivity of the oral challenge test with nickel sulphate.
- Age between 18 and 65 years.
- Written informed consent to participate in the study.
- Patients who are able to participate in all study procedures and to accept and comply with all study needs throughout the study, including the availability of suitable transportation and the time required to undergo all procedures. planned visits.
Exclusion Criteria:
- Women who are pregnant or breastfeeding.
- Patients diagnosed with organic diseases capable of affecting gastrointestinal symptoms (eg celiac disease, poorly controlled diabetes, scleroderma, chronic inflammatory bowel diseases). Lactose intolerance is not an exclusion criterion if the diagnosis has been made for more than 6 months and if the patient does not report adequate symptom relief after at least 6 months of a lactose-free diet.
- Patients who have been taking systemic probiotics, antibiotics or systemic corticosteroids within the past 30 days.
- Patients who have been taking antidepressant or anxiolytic drugs for less than a month. On the other hand, patients can be enrolled who have been taking the aforementioned drugs at a stable dosage for at least one month.
- Patients who abuse coffee, tea, coca cola and with a smoking habit.
- Patients with pacemakers because they cannot be subjected to bioimpedance analysis for the assessment of body composition.
Sites / Locations
- UOSD Allergologia e Immunologia Clinica, Fondazione Policlinico Universitario A. Gemelli IRCCS
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Datterino tomato purée from hydroponic technology
Datterino tomato purée from conventional cultivation
Arm Description
100% Italian datterino tomato purée deriving from hydroponic technology (soilless) with particular characteristics such as nickel free and zero residue.
100% Italian datterino tomato purée deriving from conventional cultivation.
Outcomes
Primary Outcome Measures
Change of gastrointestinal symptoms control
Average values of the scores relating to the individual SNAS symptoms as reported in the visual analogue scale (VAS) - Systemic Nickel Allergy Syndrome (SNAS) scale before and after taking each type of tomato sauce (hydroponic vs conventional).
This scale includes values from a minimum of zero to a maximum of ten. Higher scores indicate a worse outcome.
Secondary Outcome Measures
Change of impact on quality of life - SF-36
Difference in mean scores on quality of life questionnaire Short Form 36 Items Health Survey (SF-36) before and after each planned dietary treatment (hydroponic vs conventional tomato).
Each patient answers SF-36v2 (Italian version) questionnaire. It comprises 36-items measuring 8 dimensions of general QoL. Each question's score is coded, summed up, and transformed to a scale of 0 (worst possible health state measured by the questionnaire) to 100 (best possible health state).
Change of impact on quality of life - PGWBI
Difference in mean scores on quality of life questionnaire Psychological General Well Being Index (PGWBI) before and after each planned dietary treatment (hydroponic vs conventional tomato).
PGWBI consists of 22 questions, which deal with 6 factors (anxiety, depression, vitality, general health,self-control and well-being) constituting a global assessment. The response format is graded 1-6. This index includes values from a minimum of 0 to a maximum of 110. Higher scores indicate a better outcome.
Change of intestinal permeability
Difference in mean values of serum zonulin (a biomarker of intestinal permeability) before and after each planned dietary treatment (hydroponic vs conventional tomato puree).
Change of beta-carotene
Difference in the average values of beta-carotene [microg/dl] before and after each planned dietary treatment (hydroponic vs conventional tomato puree).
Change of Vitamin D
Difference in the average values of Vitamin D [ng/ml] before and after each planned dietary treatment (hydroponic vs conventional tomato puree).
Change of hemoglobin
Difference in the average values of hemoglobin [g/dl] before and after each planned dietary treatment (hydroponic vs conventional tomato puree).
Change of ferritin
Difference in the average values of ferritin [ng/ml] before and after each planned dietary treatment (hydroponic vs conventional tomato puree).
Change of adherence
Cross-comparison between the percentages of weekly intake [average number of days per week] of tomato puree (hydroponic tomato puree before and conventional after versus conventional tomato puree before and hydroponic after).
Full Information
NCT ID
NCT05232890
First Posted
November 17, 2021
Last Updated
April 2, 2022
Sponsor
Catholic University of the Sacred Heart
1. Study Identification
Unique Protocol Identification Number
NCT05232890
Brief Title
Hydroponic Cultivation in Systemic Nickel Allergy Syndrome
Acronym
DATTERINO
Official Title
Hydroponic Cultivation: a New Dietary Frontier in Systemic Nickel Allergy Syndrome - a Double Blind, Randomized, Controlled, Cross-over, Clinical Trial on the Use of Hydroponic Cultivated Tomato Sauce
Study Type
Interventional
2. Study Status
Record Verification Date
April 2022
Overall Recruitment Status
Completed
Study Start Date
February 26, 2021 (Actual)
Primary Completion Date
February 28, 2022 (Actual)
Study Completion Date
March 31, 2022 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Catholic University of the Sacred Heart
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Oral intake of nickel (Ni) is capable of causing the onset of systemic disorders in patients with Systemic Allergy to Nickel Syndrome (SNAS), an emerging allergic condition. Given its ubiquitous age, it is not possible to completely eliminate Ni and, therefore, it is necessary to plan a low-content diet. However, due to various factors (such as variability of Ni concentration in the soil, individual foods, variability of dietary habits and daily menus, different intake of Ni contained in the water, different intake of kitchen utensils, simultaneous intake of other substances), a restrictive diet is difficult and socially discriminating with a strongly negative impact on the quality of life of these patients.
Hydroponic agriculture in a completely controlled, aseptic, artificial, soilless environment could be an alternative for patients suffering from SNAS with known and lower concentrations of metals than those deriving from conventional agricultural techniques, which are affected by the soil of origin and practices cultivation.
The primary outcome of the study is to evaluate the possible effects of taking tomato puree deriving from hydroponic agriculture compared to tomato puree from conventional cultivation in the subjective control of SNAS symptoms, in patients following a low-diet diet.
This is an interventional, randomized, double-blind, single-center crossover study involving a cohort of SNAS patients following a low-nickel diet for at least 4-6 weeks.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Food Allergy, Food Hypersensitivity, Nickel Sensitivity
Keywords
Systemic Nickel Allergy Syndrome, Hydroponic cultivation, Tomato, Quality of life, Intestinal permeability
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
At enrollment, patients are randomized to one of the following study groups: Group A and Group B:
Treatment arm A: daily intake of minimum 100ml - maximum 200ml of 100% Italian datterino tomato puree deriving from hydroponic technology (soilless), contained in a 720ml bottle.
Treatment arm B: daily intake of minimum 100ml - maximum 200ml of 100% Italian datterino tomato puree deriving from conventional cultivation, contained in a 720ml bottle.
After this initial treatment phase, both study groups follow a 2-week wash-out period, following a low-nickel diet.
At the end of the wash-out phase, the two groups cross-over. Therefore, Group A is assigned to treatment arm B, and vice versa, for a period of 12 weeks.
Masking
ParticipantCare ProviderInvestigator
Masking Description
The study product and the comparator product are provided in identical packaging, the labeling shows the randomization number which, however, only the Outcomes Assessor is able to refer to the type of treatment assigned. The organoleptic characteristics of the two products are as similar as possible. The instructions given to patients regarding the preparation and consumption of the products are the same for both products.
Allocation
Randomized
Enrollment
30 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Datterino tomato purée from hydroponic technology
Arm Type
Experimental
Arm Description
100% Italian datterino tomato purée deriving from hydroponic technology (soilless) with particular characteristics such as nickel free and zero residue.
Arm Title
Datterino tomato purée from conventional cultivation
Arm Type
Active Comparator
Arm Description
100% Italian datterino tomato purée deriving from conventional cultivation.
Intervention Type
Other
Intervention Name(s)
Datterino tomato purée from hydroponic technology
Intervention Description
Daily intake of minimum 100ml - maximum 200ml of 100% Italian datterino tomato puree deriving from hydroponic technology (soilless), contained in a 720ml bottle.
Intervention Type
Other
Intervention Name(s)
Datterino tomato puree from conventional cultivation
Intervention Description
Daily intake of at least 100ml - maximum 200ml of 100% Italian datterino tomato puree deriving from conventional cultivation, contained in a 720 ml bottle.
Primary Outcome Measure Information:
Title
Change of gastrointestinal symptoms control
Description
Average values of the scores relating to the individual SNAS symptoms as reported in the visual analogue scale (VAS) - Systemic Nickel Allergy Syndrome (SNAS) scale before and after taking each type of tomato sauce (hydroponic vs conventional).
This scale includes values from a minimum of zero to a maximum of ten. Higher scores indicate a worse outcome.
Time Frame
Immediately after the intervention
Secondary Outcome Measure Information:
Title
Change of impact on quality of life - SF-36
Description
Difference in mean scores on quality of life questionnaire Short Form 36 Items Health Survey (SF-36) before and after each planned dietary treatment (hydroponic vs conventional tomato).
Each patient answers SF-36v2 (Italian version) questionnaire. It comprises 36-items measuring 8 dimensions of general QoL. Each question's score is coded, summed up, and transformed to a scale of 0 (worst possible health state measured by the questionnaire) to 100 (best possible health state).
Time Frame
Change from baseline index at 12 and 26 weeks.
Title
Change of impact on quality of life - PGWBI
Description
Difference in mean scores on quality of life questionnaire Psychological General Well Being Index (PGWBI) before and after each planned dietary treatment (hydroponic vs conventional tomato).
PGWBI consists of 22 questions, which deal with 6 factors (anxiety, depression, vitality, general health,self-control and well-being) constituting a global assessment. The response format is graded 1-6. This index includes values from a minimum of 0 to a maximum of 110. Higher scores indicate a better outcome.
Time Frame
Change from baseline index at 12 and 26 weeks.
Title
Change of intestinal permeability
Description
Difference in mean values of serum zonulin (a biomarker of intestinal permeability) before and after each planned dietary treatment (hydroponic vs conventional tomato puree).
Time Frame
Change from baseline index at 12 and 26 weeks.
Title
Change of beta-carotene
Description
Difference in the average values of beta-carotene [microg/dl] before and after each planned dietary treatment (hydroponic vs conventional tomato puree).
Time Frame
Change from baseline index at 12 and 26 weeks.
Title
Change of Vitamin D
Description
Difference in the average values of Vitamin D [ng/ml] before and after each planned dietary treatment (hydroponic vs conventional tomato puree).
Time Frame
Change from baseline index at 12 and 26 weeks.
Title
Change of hemoglobin
Description
Difference in the average values of hemoglobin [g/dl] before and after each planned dietary treatment (hydroponic vs conventional tomato puree).
Time Frame
Change from baseline index at 12 and 26 weeks.
Title
Change of ferritin
Description
Difference in the average values of ferritin [ng/ml] before and after each planned dietary treatment (hydroponic vs conventional tomato puree).
Time Frame
Change from baseline index at 12 and 26 weeks.
Title
Change of adherence
Description
Cross-comparison between the percentages of weekly intake [average number of days per week] of tomato puree (hydroponic tomato puree before and conventional after versus conventional tomato puree before and hydroponic after).
Time Frame
After 12 weeks, after 26 weeks.
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients with documented diagnosis of SNAS: a) history of SNAS (coexistence of typical skin symptoms and gastrointestinal symptoms); b) positive nickel sulphate patch test; c) clinical improvement of at least 70% after 4-6 weeks of low-nickel diet; d) positivity of the oral challenge test with nickel sulphate.
Age between 18 and 65 years.
Written informed consent to participate in the study.
Patients who are able to participate in all study procedures and to accept and comply with all study needs throughout the study, including the availability of suitable transportation and the time required to undergo all procedures. planned visits.
Exclusion Criteria:
Women who are pregnant or breastfeeding.
Patients diagnosed with organic diseases capable of affecting gastrointestinal symptoms (eg celiac disease, poorly controlled diabetes, scleroderma, chronic inflammatory bowel diseases). Lactose intolerance is not an exclusion criterion if the diagnosis has been made for more than 6 months and if the patient does not report adequate symptom relief after at least 6 months of a lactose-free diet.
Patients who have been taking systemic probiotics, antibiotics or systemic corticosteroids within the past 30 days.
Patients who have been taking antidepressant or anxiolytic drugs for less than a month. On the other hand, patients can be enrolled who have been taking the aforementioned drugs at a stable dosage for at least one month.
Patients who abuse coffee, tea, coca cola and with a smoking habit.
Patients with pacemakers because they cannot be subjected to bioimpedance analysis for the assessment of body composition.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Eleonora Nucera, Prof., MD
Organizational Affiliation
Catholic University of Sacred Heart
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Angela Rizzi, MD, PhD
Organizational Affiliation
Catholic University of Sacred Heart
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Antonio Gasbarrini, Prof., MD
Organizational Affiliation
Catholic University of Sacred Heart
Official's Role
Study Director
Facility Information:
Facility Name
UOSD Allergologia e Immunologia Clinica, Fondazione Policlinico Universitario A. Gemelli IRCCS
City
Roma
ZIP/Postal Code
00168
Country
Italy
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Hydroponic Cultivation in Systemic Nickel Allergy Syndrome
We'll reach out to this number within 24 hrs